Phase 2 Study of Pembrolizumab in Combination with Gemcitabine and Cisplatin as Neoadjuvant Therapy

dbGaP FAQdbGaP Access Request Video Tutorial

Platforms

dbGaP

View in dbGaP

phs003452.v1.p1

APIs

Consent Codes

DS-CA

Focus / Diseases

Urinary Bladder Neoplasms

Study Design

Case Set

Data Types

RNA-Seq, WXS

Subjects

37